Nektar Therapeutics NKTR
$58.85
-0.89%
at last close
Financials (TTM)
- Revenue
- $54.59 million
- Net Income
- $-157,127,000
- Net Margin
- -287.84%
- Return on Equity
- -17.40%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 2.24
- Price / Sales
- 37.14
Over the trailing twelve months, Nektar Therapeutics generated revenue of $54.59 million and net income of $-157,127,000, a net margin of -287.84%.
At the last closing price of $58.85, NKTR trades at 37.14 times sales, with a market capitalization of $2.03 billion.
Key Stats
- Last Close
- $58.85
- Market Cap
- $2.03 billion
- 52-Week Range
- $26.45 – $109.00
- Average Volume
- 977K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.